These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 7931228

  • 1. Amphetamine-metabolites of deprenyl involved in protection against neurotoxicity induced by MPTP and 2'-methyl-MPTP.
    Sziráki I, Kardos V, Patthy M, Pátfalusi M, Gaál J, Solti M, Kollár E, Singer J.
    J Neural Transm Suppl; 1994; 41():207-19. PubMed ID: 7931228
    [Abstract] [Full Text] [Related]

  • 2. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
    Muralikrishnan D, Samantaray S, Mohanakumar KP.
    Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
    [Abstract] [Full Text] [Related]

  • 3. Age-dependent effects of the 2'-methyl analog of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine: prevention by inhibitors of monoamine oxidase B.
    Finnegan KT, Irwin I, Delanney LE, Langston JW.
    J Pharmacol Exp Ther; 1995 May; 273(2):716-20. PubMed ID: 7752075
    [Abstract] [Full Text] [Related]

  • 4. PF 9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine], a new MAO-B inhibitor, attenuates MPTP-induced depletion of striatal dopamine levels in C57/BL6 mice.
    Perez V, Unzeta M.
    Neurochem Int; 2003 Feb; 42(3):221-9. PubMed ID: 12427476
    [Abstract] [Full Text] [Related]

  • 5. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
    Kupsch A, Sautter J, Götz ME, Breithaupt W, Schwarz J, Youdim MB, Riederer P, Gerlach M, Oertel WH.
    J Neural Transm (Vienna); 2001 Feb; 108(8-9):985-1009. PubMed ID: 11716151
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. L-Deprenyl and MDL72974 do not improve the recovery of dopaminergic cells following systemic administration of MPTP in mouse.
    Thiffault C, Lamarre-Théroux L, Quirion R, Poirier J.
    Brain Res Mol Brain Res; 1997 Mar; 44(2):238-44. PubMed ID: 9073165
    [Abstract] [Full Text] [Related]

  • 8. Different effects of monoamine oxidase inhibition on MPTP depletion of heart and brain catecholamines in mice.
    Fuller RW, Hemrick-Luecke SK, Kindt MV, Heikkila RE.
    Life Sci; 1988 Mar; 42(3):263-71. PubMed ID: 3121972
    [Abstract] [Full Text] [Related]

  • 9. Neuroprotection by (R)-deprenyl and 7-nitroindazole in the MPTP C57BL/6 mouse model of neurotoxicity.
    Castagnoli K, Palmer S, Castagnoli N.
    Neurobiology (Bp); 1999 Mar; 7(2):135-49. PubMed ID: 10591048
    [Abstract] [Full Text] [Related]

  • 10. Deprenyl antagonizes acute lethality of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.
    Fuller RW, Hemrick-Luecke SK, Perry KW.
    J Pharmacol Exp Ther; 1988 Nov; 247(2):531-5. PubMed ID: 3141609
    [Abstract] [Full Text] [Related]

  • 11. Role for monoamine oxidase-A (MAO-A) in the bioactivation and nigrostriatal dopaminergic neurotoxicity of the MPTP analog, 2'Me-MPTP.
    Kindt MV, Youngster SK, Sonsalla PK, Duvoisin RC, Heikkila RE.
    Eur J Pharmacol; 1988 Feb 09; 146(2-3):313-8. PubMed ID: 3131149
    [Abstract] [Full Text] [Related]

  • 12. Neuroprotective rather than neurorescue or neurorestorative effect of selegiline against MPTP-induced dopaminergic toxicity.
    Wu WR, Zhu XZ, Guan HJ, Wang RG, Ji XQ.
    Zhongguo Yao Li Xue Bao; 1999 Feb 09; 20(2):146-50. PubMed ID: 10437162
    [Abstract] [Full Text] [Related]

  • 13. Characteristics of 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the mouse.
    Sonsalla PK, Youngster SK, Kindt MV, Heikkila RE.
    J Pharmacol Exp Ther; 1987 Sep 09; 242(3):850-7. PubMed ID: 2888874
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of monoamine oxidase contributes to the protective effect of 7-nitroindazole against MPTP neurotoxicity.
    Di Monte DA, Royland JE, Anderson A, Castagnoli K, Castagnoli N, Langston JW.
    J Neurochem; 1997 Oct 09; 69(4):1771-3. PubMed ID: 9326308
    [Abstract] [Full Text] [Related]

  • 15. Methamphetamine protects against MPTP neurotoxicity in C57BL mice.
    Sziráki I, Kardos V, Patthy M, Pátfalusi M, Budai G.
    Eur J Pharmacol; 1994 Jan 14; 251(2-3):311-4. PubMed ID: 8149986
    [Abstract] [Full Text] [Related]

  • 16. Monoamine oxidase and the bioactivation of MPTP and related neurotoxins: relevance to DATATOP.
    Heikkila RE, Terleckyj I, Sieber BA.
    J Neural Transm Suppl; 1990 Jan 14; 32():217-27. PubMed ID: 2128498
    [Abstract] [Full Text] [Related]

  • 17. Development of fluorinated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs with potent nigrostriatal toxicity for potential use in positron emission tomography studies.
    Harik SI, Riachi NJ, Hritz MA, Berridge MS, Sayre LM.
    J Pharmacol Exp Ther; 1993 Aug 14; 266(2):790-5. PubMed ID: 8355208
    [Abstract] [Full Text] [Related]

  • 18. Attenuation of MPTP-induced dopaminergic neurotoxicity by TV3326, a cholinesterase-monoamine oxidase inhibitor.
    Sagi Y, Weinstock M, Youdim MB.
    J Neurochem; 2003 Jul 14; 86(2):290-7. PubMed ID: 12871570
    [Abstract] [Full Text] [Related]

  • 19. Neuroprotective aspects of a novel MAO-B inhibitor PF9601N.
    Pérez V, Morón J, Pastó M, Unzeta M.
    Neurobiology (Bp); 2000 Jul 14; 8(3-4):231-6. PubMed ID: 11225513
    [Abstract] [Full Text] [Related]

  • 20. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neuroblastic apoptosis in the subventricular zone is caused by 1-methy-4-phenylpiridinium (MPP(+)) converted from MPTP through MAO-B.
    Ito T, Suzuki K, Uchida K, Nakayama H.
    Exp Toxicol Pathol; 2012 Nov 14; 64(7-8):761-5. PubMed ID: 21324658
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.